Ushio Inc
TSE:6925
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 800.5
2 202.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Ushio Inc
Current Assets | 190.9B |
Cash & Short-Term Investments | 60B |
Receivables | 36.5B |
Other Current Assets | 94.4B |
Non-Current Assets | 125.9B |
Long-Term Investments | 50B |
PP&E | 50.1B |
Intangibles | 8.1B |
Other Non-Current Assets | 17.7B |
Current Liabilities | 48.6B |
Accounts Payable | 15.3B |
Accrued Liabilities | 2.8B |
Short-Term Debt | 2.4B |
Other Current Liabilities | 28.2B |
Non-Current Liabilities | 50.5B |
Long-Term Debt | 39.1B |
Other Non-Current Liabilities | 11.4B |
Balance Sheet
Ushio Inc
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
60 765
|
54 595
|
63 963
|
74 725
|
85 655
|
60 679
|
73 670
|
88 687
|
64 219
|
65 651
|
|
Cash Equivalents |
60 765
|
54 595
|
63 963
|
74 725
|
85 655
|
60 679
|
73 670
|
88 687
|
64 219
|
65 651
|
|
Short-Term Investments |
13 503
|
7 893
|
8 342
|
4 851
|
4 405
|
4 222
|
2 915
|
4 937
|
2 591
|
4 120
|
|
Total Receivables |
38 501
|
37 299
|
41 239
|
40 665
|
37 846
|
38 283
|
31 308
|
32 606
|
36 466
|
38 070
|
|
Accounts Receivables |
38 501
|
37 299
|
41 239
|
40 665
|
37 846
|
38 283
|
31 308
|
32 606
|
36 466
|
38 070
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
52 246
|
56 636
|
52 420
|
54 261
|
62 440
|
57 181
|
57 879
|
65 342
|
83 454
|
92 050
|
|
Other Current Assets |
13 759
|
13 750
|
14 370
|
10 438
|
9 773
|
10 470
|
10 587
|
10 136
|
11 789
|
11 610
|
|
Total Current Assets |
178 774
|
170 173
|
180 334
|
184 940
|
200 119
|
170 835
|
176 359
|
201 708
|
198 519
|
211 501
|
|
PP&E Net |
40 014
|
42 310
|
44 809
|
41 578
|
43 050
|
44 242
|
44 822
|
46 162
|
50 480
|
45 854
|
|
PP&E Gross |
40 014
|
42 310
|
44 809
|
41 578
|
43 050
|
44 242
|
44 822
|
46 162
|
50 480
|
45 854
|
|
Accumulated Depreciation |
60 118
|
60 809
|
63 883
|
66 133
|
68 861
|
70 526
|
75 443
|
81 709
|
84 583
|
85 777
|
|
Intangible Assets |
3 621
|
5 170
|
5 435
|
3 953
|
3 272
|
3 048
|
3 076
|
2 756
|
2 782
|
7 816
|
|
Goodwill |
3 477
|
5 616
|
3 788
|
2 358
|
1 370
|
698
|
335
|
235
|
252
|
780
|
|
Note Receivable |
22
|
0
|
21
|
170
|
347
|
18
|
517
|
15
|
20
|
28
|
|
Long-Term Investments |
63 252
|
65 747
|
67 923
|
63 819
|
51 005
|
50 278
|
56 364
|
59 146
|
58 484
|
54 305
|
|
Other Long-Term Assets |
5 382
|
5 500
|
6 120
|
8 485
|
7 465
|
5 785
|
8 802
|
11 074
|
13 085
|
17 262
|
|
Other Assets |
3 477
|
5 616
|
3 788
|
2 358
|
1 370
|
698
|
335
|
235
|
252
|
780
|
|
Total Assets |
294 542
N/A
|
294 525
0%
|
308 430
+5%
|
305 303
-1%
|
306 628
+0%
|
274 904
-10%
|
290 275
+6%
|
321 096
+11%
|
323 622
+1%
|
337 546
+4%
|
|
Liabilities | |||||||||||
Accounts Payable |
17 786
|
17 797
|
16 859
|
21 414
|
21 665
|
18 730
|
16 356
|
21 164
|
26 205
|
21 648
|
|
Accrued Liabilities |
2 654
|
2 472
|
2 050
|
2 185
|
2 047
|
1 999
|
2 021
|
2 699
|
2 530
|
2 693
|
|
Short-Term Debt |
4 272
|
5 049
|
5 763
|
6 950
|
10 008
|
3 110
|
6 058
|
2 185
|
3 921
|
2 455
|
|
Current Portion of Long-Term Debt |
1 376
|
3 090
|
4 701
|
1 888
|
8 611
|
6 386
|
3 600
|
16 414
|
796
|
940
|
|
Other Current Liabilities |
18 798
|
21 055
|
25 219
|
21 737
|
27 241
|
17 504
|
19 972
|
29 931
|
28 958
|
31 516
|
|
Total Current Liabilities |
44 886
|
49 463
|
54 592
|
54 174
|
69 572
|
47 729
|
48 007
|
72 393
|
62 410
|
59 252
|
|
Long-Term Debt |
8 440
|
6 413
|
17 307
|
17 989
|
10 576
|
12 919
|
15 247
|
61
|
3 599
|
29 456
|
|
Deferred Income Tax |
5 792
|
4 325
|
6 459
|
8 975
|
4 592
|
3 863
|
7 005
|
7 823
|
7 997
|
6 706
|
|
Minority Interest |
2 798
|
2 590
|
643
|
229
|
152
|
89
|
77
|
84
|
12
|
11
|
|
Other Liabilities |
16 701
|
23 028
|
16 783
|
8 859
|
8 634
|
9 688
|
8 836
|
5 617
|
5 511
|
5 157
|
|
Total Liabilities |
78 617
N/A
|
85 819
+9%
|
95 784
+12%
|
90 226
-6%
|
93 526
+4%
|
74 288
-21%
|
79 172
+7%
|
85 978
+9%
|
79 529
-8%
|
100 582
+26%
|
|
Equity | |||||||||||
Common Stock |
19 556
|
19 556
|
19 556
|
19 556
|
19 556
|
19 556
|
19 556
|
19 556
|
19 556
|
19 556
|
|
Retained Earnings |
143 883
|
151 856
|
155 545
|
163 217
|
162 936
|
156 082
|
152 448
|
161 877
|
164 332
|
140 163
|
|
Additional Paid In Capital |
28 301
|
27 672
|
27 772
|
27 771
|
27 727
|
27 727
|
27 727
|
27 727
|
27 767
|
27 767
|
|
Unrealized Security Profit/Loss |
29 892
|
0
|
30 407
|
24 247
|
14 445
|
11 874
|
18 280
|
21 399
|
19 869
|
20 146
|
|
Treasury Stock |
12 850
|
0
|
17 216
|
17 212
|
10 811
|
9 148
|
9 055
|
9 032
|
8 733
|
9 155
|
|
Other Equity |
7 143
|
5 423
|
3 418
|
2 502
|
751
|
5 475
|
2 147
|
13 591
|
21 302
|
38 487
|
|
Total Equity |
215 925
N/A
|
208 706
-3%
|
212 646
+2%
|
215 077
+1%
|
213 102
-1%
|
200 616
-6%
|
211 103
+5%
|
235 118
+11%
|
244 093
+4%
|
236 964
-3%
|
|
Total Liabilities & Equity |
294 542
N/A
|
294 525
0%
|
308 430
+5%
|
305 303
-1%
|
306 628
+0%
|
274 904
-10%
|
290 275
+6%
|
321 096
+11%
|
323 622
+1%
|
337 546
+4%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
131
|
129
|
128
|
128
|
126
|
121
|
121
|
121
|
118
|
102
|